** U.S.-listed shares of cannabis company drop 4 pct to $19.53
** Q4 revenue falls short of analysts’ estimates; posts wider-than-expected qtrly loss per share, according to Refinitiv data
** Shares in Canopy Growth, Aurora Cannabis and Tilray shed between 0.4 pct to 0.5 pct
** More than 9.2 mln CRON shares traded, making it among the most actively traded stock across U.S. exchanges
** Of the 9 brokerages covering the Canadian stock , 3 rate it “buy” or higher, 4 “hold” and 2 “sell” or lower
** Including session moves, U.S. shares of Cronos up 89 pct this year, vs 86 pct climb in ACB and 65 pct rise in CGC (Reporting by Medha Singh in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.